(Q54125196)

25 May 2018

title

A retrospective chart review of uncontrolled use of metformin as an add-on therapy in type 2 diabetes. (English)

1 reference

25 May 2018

0 references

1 reference

Johnson M

1

1 reference

25 May 2018

Krosnick A

2

1 reference

25 May 2018

Carson P

3

1 reference

25 May 2018

McDade AM

4

1 reference

25 May 2018

Laraway K

5

1 reference

25 May 2018

publication date

1 July 1998

1 reference

25 May 2018

published in

Clinical Therapeutics

1 reference

25 May 2018

volume

20

1 reference

25 May 2018

issue

4

1 reference

25 May 2018

page(s)

691-698

1 reference

25 May 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

7 January 2021

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

7 January 2021

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

7 January 2021

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

7 January 2021

Improvement in in vitro insulin action after one month of insulin therapy in obese noninsulin-dependent diabetics. Measurements of glucose transport and metabolism, insulin binding, and lipolysis in isolated adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

1 reference

7 January 2021

Metformin for obese, insulin-treated diabetic patients: improvement in glycaemic control and reduction of metabolic risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2898%2980132-X

7 January 2021

10.1016/S0149-2918(98)80132-X

Identifiers

DOI

1 reference

25 May 2018

1 reference

25 May 2018